
Cytocom receives FDA clearance of IND for Phase 2 clinical trial of CYTO-205 as treatment for COVID-19
FORT COLLINS -- Cytocom, Inc. announced the U.S. Food and Drug Administration (FDA) has cleared the Investigational New Drug (IND) application for a Phase 2 clinical trial to evaluate the safety... Read More
Thursday March 18, 2021

Fusion Robotics receives FDA 510(k) clearance for spinal navigation & robotics system
BOULDER -- Fusion Robotics LLC, a spinal robotics and navigation company, announced receiving 510(k) clearance to market the company’s 3D imaging compatible navigation and robotic targeting... Read More
Friday February 26, 2021

New COVID-19 antibody test receives emergency use authorization by FDA
DENVER --Scientists at the University of Denver have tested a new antibody test for COVID-19 that can predict if a patient will experience mild versus more severe symptoms of the virus. The... Read More
Thursday February 4, 2021

Ampio gets FDA feedback on proposed modifications to special protocol assessment for Ampion
ENGLEWOOD -- Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) today announced it received guidance from the U.S Food Drug Administration regarding the impact of COVID-19 on its Phase III clinical... Read More
Wednesday December 30, 2020

Clovis Oncology submits Investigational New Drug applications to FDA for FAP-2286 for therapeutic and imaging clinical trial
BOULDER -- Clovis Oncology, Inc. (NASDAQ: CLVS) today announced it has completed submission of two Investigational New Drug (IND) applications to the U.S. Food and Drug Administration (FDA) for... Read More
Tuesday December 29, 2020

Ampio enters into collaborative research agreements to explore additional clinical indications for Ampion
ENGLEWOOD -- Ampio Pharmaceuticals, Inc . (NYSE American: AMPE) announced it has entered into two collaborative research agreements to explore new clinical indications for its immunomodulatory drug,... Read More
Monday December 14, 2020

SomaLogic announces FDA collaboration to advance biosimilar development
BOULDER -- SomaLogic, Inc . announced an agreement with the U.S. Food and Drug Administration’s Division of Applied Regulatory Science to evaluate the utility of large-scale analysis of proteins... Read More
Monday November 2, 2020

FDA grants IND and approves clinical trial protocol of inhaled Ampion for COVID-19 patients
ENGLEWOOD-- Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) announced it has received an Investigational New Drug designation from the U.S. Food and Drug Administration, allowing the company to... Read More
Monday September 21, 2020